Only three out of twenty - one patients reached the primary endpoint of progression - free survival at 18 weeks .
These three patients remained progression - free for 21 , 34 , and 42 weeks .
Only three out of twenty - one patients reached the primary endpoint of progression - free survival at 18 weeks , but these three patients remained progression - free for 21 , 34 , and 42 weeks .